Story perspectives

Eli Lilly, Walmart Team Up to Offer Zepbound Access

10/29/2025

28 3

Summary

Story summary

Eli Lilly and Company and Walmart Inc. will offer Zepbound (tirzepatide) through LillyDirect, with direct-to-consumer pricing at Walmart pharmacies nationwide beginning in mid-November 2025.
Zepbound single-dose vials will be available for self-pay, with the lowest dose priced at $349 per month and higher doses at $499.
Patients can choose between home delivery and local pickup.
The collaboration marks a significant step in improving patient access to essential medications.

1 of 1

Story summary

Eli Lilly and Company and Walmart Inc. will offer Zepbound (tirzepatide) through LillyDirect, with direct-to-consumer pricing at Walmart pharmacies nationwide beginning in mid-November 2025.
Zepbound single-dose vials will be available for self-pay, with the lowest dose priced at $349 per month and higher doses at $499.
Patients can choose between home delivery and local pickup.
The collaboration marks a significant step in improving patient access to essential medications.